Takara Bio Europe AB and PanCryos Announce Licensing Agreement to Enable Development of Cell-Based Therapy for Diabetes Kumar Jeetendra | May 5, 2021 Göteberg, Sweden – May 05, 2021 – Life Science Newswire – Takara Bio Europe AB (TBEAB) and PanCryos are pleased to announce that they have reached a licensing agreement surrounding TBEAB’s clinical-grade human embryonic stem (hES) cell lines. PanCryos has established a simplified and effective method to generate stem cell-derived, glucose-responsive beta cells and is …
